First human test of PRX019 drug shows no major red flags
Knowledge-focused
Completed
This early-stage study tested the safety of a new drug called PRX019 in 50 healthy adults. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. The goal was to see if PRX019 is safe enough for further testing.
Phase: PHASE1 • Sponsor: Prothena Biosciences Ltd. • Aim: Knowledge-focused
Last updated May 26, 2026 11:47 UTC